课题基金 / 基金详情

Natural History of Pre-diabetic Autoimmunity (DAISY)

Natural History of Pre-diabetic Autoimmunity (DAISY)
糖尿病前期自身免疫的自然史 (DAISY)
批准号:
7260523
负责人:
MARIAN J REWERS
金额:
$84.03万
依托单位国家:
美国
项目类别:
财政年份:
1994
资助国家:
美国
项目状态:
已结题
起止时间:
1994-11-01 至 2011-05-31
关键词:
AddressAgeAge-MonthsAllelesAppearanceAutoantibodiesAutoimmune DiseasesAutoimmunityBirthBirth OrderBlood ScreeningBlood specimenBreast FeedingC-PeptideCattleCellsCerealsChildChildhoodClinic VisitsCytomegalovirusData SetDay CareDevelopmentDiabetes MellitusDietDoctor of PhilosophyEnrollmentEnterovirusEnvironmentEnvironmental ExposureEnvironmental Risk FactorEpitopesEthnic OriginEventExposure toFamily history ofFecesFrequenciesGeneral PopulationGenesGeneticGenetic MarkersGenetic PolymorphismGenetic RiskGenotypeGlutenGoalsHLA-A AntigensHLA-A geneHLA-A2 AntigenHLA-DRB1*0401HaplotypesHerpesviridaeHerpesvirus 1HouseholdHuman Herpesvirus 2Human Herpesvirus 4ICA512 autoantibodyImmunizationIncidenceInfantInfectionInsulinInsulin-Dependent Diabetes MellitusIntakeIntercellular adhesion molecule 1Islets of LangerhansLaboratoriesLifeMapsMeatMilkNatural HistoryNested Case-Control StudyNewborn InfantNumbersPaperParentsParticipantPatientsPersonsPopulationPopulation ControlProductionProgress ReportsPublishingRaceRateRelative (related person)Relative RisksReportingResearch DesignResearch PersonnelResolutionRiskRisk FactorsRotavirusSamplingScreening procedureSiblingsSimplexvirusStratificationTestingTimeUmbilical Cord BloodVaccinationVaccinesViral AntibodiesVitamin D3 ReceptorVitaminsWomanbasecase controlcohortdiabetes riskdiabeticearly childhoodfollow-upfruits and vegetablesgene environment interactiongenetic risk factorhuman leukocyte antigen geneisletmenpet animalprobandprogramsprospectiveresponsetransmission processviral RNA

项目摘要

项目成果

MARIAN J REWERS的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This project, called Diabetes AutoimmunityStudy in the Young (DAISY) began in July 1993 and allowed us to establish two unique cohorts of very young children who are at up to 20-fold increased risk of type 1 diabetes: 1) a cohort of 693 siblings and offspring (current median age 4.5 years) of persons with type 1 diabetes and 1007 of their relatives; and 2) a cohort of 1,069newborns (current median age 3.1 years) with type 1 diabetes-associated HLA-DR,DQ alleles, identified through a cord blood screening of 21,713 general population children without a diabetic relative and 1,491 of their relatives. To date, a short prospective follow-up of these cohorts has already provided new important information concerning the natural history of b-cell autoimmunity and diabetes in early childhood. Based on our findings, we are proposing to follow these cohorts through the period of the highest risk of b-cell autoimmunity and to address the following goals: Specific Aims 1. To continue enrollment and follow-up, until the median age of 10yrs,of the existing cohorts of siblings/offspring and of newborns at high and moderate genetic risk detected through general population HLA-DR,DQ screening to: a) former define the incidence of b-cell autoimmunityby age,race/ethnicity, HLA-genotype, and family history of type 1 diabetes; b) formally evaluate candidate autoimmunity/diabetes risk factors available for all participants, e.g., early childhood diet, reported infections, and vaccination; and c) sustain this population laboratory for additional studies of type 1 diabetes and other autoimmune diseases. 2. To continue current and initiate new case-control studies, nested in the cohorts, of selected environmental and genetic risk factors for: a) b-cell autoimmunityand its persistence; and b) progression from b-cell autoimmunityto diabetes 3. Based on our findings, initiate intensive follow-up from birth of eighty highest risk children (HLA-DR3/4,DQB1 *0302 relatives) with monthly filter paper blood samples and weekly stool samples in addition to tri-monthly clinic visits. 4. To explore gene-environment interactions using combined approaches of case-control and case parent analyses. Our study is filling important gaps in the understanding of the events leading to type 1 diabetes in early childhood by providing the first unbiased population estimates of the incidence of b-cell autoimmunityand of the relative risks associated with candidate environmental and genetic factors.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Clinical Resource Core
  • 批准号:
    10392978
  • 项目类别:
  • 资助金额:
    $14.44万
  • 财政年份:
    2020
  • 负责人:
    MARIAN J REWERS
  • 依托单位:
Clinical Resource Core
  • 批准号:
    10646146
  • 项目类别:
  • 资助金额:
    $14.23万
  • 财政年份:
    2020
  • 负责人:
    MARIAN J REWERS
  • 依托单位:
Developing Pediatric Diabetes Investigators for the Future
  • 批准号:
    9188204
  • 项目类别:
  • 资助金额:
    $39.51万
  • 财政年份:
    2011
  • 负责人:
    MARIAN J REWERS
  • 依托单位:
Integrated Cardio-Renal Risk Prediction Models in Type 1 Diabetes
  • 批准号:
    7829755
  • 项目类别:
  • 资助金额:
    $49.69万
  • 财政年份:
    2010
  • 负责人:
    MARIAN J REWERS
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: